Peptide bioregulatorEvidence: Russian preclinicalRUO · not approved
Research Use Only. Not an approved medicine and not for human use. Educational only — no dosing or medical advice.
What it is
Pancragen is a short synthetic peptide bioregulator marketed toward pancreatic tissue.
Proposed mechanism
Proposed tissue-selective bioregulation (Khavinson hypothesis); not independently established.1
State of the evidence
Russian preclinical; no approval.
Regulatory & status
Not approved; RUO.
Reconstitution (reference only)
Lab-handling reference only — not a preparation or dosing instruction: 2 mL (200 units) reconstitution solution per 20 mg vial. See the reconstitution calculator for the arithmetic. This page does not provide dosing guidance.
For educational and research purposes only. This content is not medical advice. Compounds referenced are research use only and not intended to diagnose, treat, cure, or prevent any disease. Free Peptide University does not sell compounds.